Literature DB >> 14673070

Preoperative therapy versus immediate surgery in nonmetastatic osteosarcoma.

G Bacci, S Ferrari, A Longhi, C Forni, P Ruggieri, A Briccoli, M De Paolis, E Setola.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14673070     DOI： 10.1200/JCO.2003.99.157

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.

Authors:  P M Anderson; P Meyers; E Kleinerman; K Venkatakrishnan; D P Hughes; C Herzog; W Huh; R Sutphin; Y M Vyas; V Shen; A Warwick; N Yeager; C Oliva; B Wang; Y Liu; A Chou
Journal:  Pediatr Blood Cancer       Date:  2013-08-31       Impact factor: 3.167

2.  Chemotherapy response analysis for osteosarcom with intra-arterial chemotherapy by subcutaneous implantable delivery system.

Authors:  Dingfeng Li; Qiu Cui; Yaosheng Liu; Xiaohong Wang; Cheng Liu; Shubin Liu; Yanjun Zeng
Journal:  Pathol Oncol Res       Date:  2011-06-30       Impact factor: 3.201

Review 3.  Management of osteosarcoma.

Authors:  Jeremy Whelan; Beatrice Seddon; Martha Perisoglou
Journal:  Curr Treat Options Oncol       Date:  2006-11

4.  Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma.

Authors:  Christopher E Lietz; Erik T Newman; Andrew D Kelly; David H Xiang; Ziying Zhang; Caroline A Luscko; Santiago A Lozano-Calderon; David H Ebb; Kevin A Raskin; Gregory M Cote; Edwin Choy; G Petur Nielsen; Benjamin Haibe-Kains; Martin J Aryee; Dimitrios Spentzos
Journal:  Commun Biol       Date:  2022-03-08

5.  Suboptimal chemotherapy is an adverse prognostic factor in osteosarcoma.

Authors:  Bicheng Yong; Pingxian Tan; Junqiang Yin; Changye Zou; Xianbiao Xie; Jin Wang; Gang Huang; Qianyong Wang; Jingnan Shen
Journal:  World J Surg Oncol       Date:  2012-09-17       Impact factor: 2.754

6.  Classification, imaging, biopsy and staging of osteosarcoma.

Authors:  Zile Singh Kundu
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.